Loading
Gestational Diabetes Research and Management · Journal article
JAMA Network Open · August 12, 2026
Well-designed and adequately powered for the question it asks.
This large retrospective cohort study found that gestational diabetes is associated with substantially elevated postpartum risk of dysglycemia (type 2 diabetes AHR 10.02, prediabetes AHR 5.32), metabolic syndrome (AHR 2.72), dyslipidemia, hypertension, obesity, and composite cardiovascular disease (AHR 1.28), but not chronic kidney disease, over a median 2.4-year follow-up. The findings support extending postpartum surveillance after gestational diabetes beyond glycaemic control to include broader cardiometabolic monitoring.
Retrospective cohort study. Commercially insured females aged 12–55 years with a single delivery and no preexisting cardiometabolic disorders before delivery; mean age 28.0 (5.8) years; enrolled April 1, 2007 to October 12, 2023.. Intervention: Gestational diabetes during pregnancy. Compared with: No gestational diabetes during pregnancy. n = 1,153,998. Merative MarketScan commercial database (United States).
Type 2 diabetes: time-averaged AHR 10.02 (95% CI, 9.53–10.52) with crude incidence 9.9 vs 1.0 per 1000 person-years Prediabetes: AHR 5.32 (95% CI, 5.12–5.53) with crude incidence 12.9 vs 2.5 per 1000 person-years Metabolic syndrome: AHR 2.72 (95% CI, 2.49–2.98)
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians should counsel women with a history of gestational diabetes about substantially elevated postpartum risk of type 2 diabetes, prediabetes, and other cardiometabolic disorders. Routine postpartum care should extend beyond glucose monitoring to include regular surveillance of blood pressure, lipids, weight, and metabolic syndrome components.
Large retrospective cohort study with over 1.15 million participants demonstrating consistent, adjusted associations between gestational diabetes and multiple postpartum cardiometabolic disorders with narrow confidence intervals, though observational design and commercial insurance population limit generalizability.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians should counsel women with a history of gestational diabetes about substantially elevated postpartum risk of type 2 diabetes, prediabetes, and other cardiometabolic disorders. Routine postpartum care should extend beyond glucose monitoring to include regular surveillance of blood pressure, lipids, weight, and metabolic syndrome components.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Importance Gestational diabetes is associated with future cardiometabolic risk, but postpartum evidence across the cardiovascular-kidney-metabolic (CKM) disorder spectrum remains limited. Objective To characterize the timing and magnitude of incident postpartum CKM disorders after a pregnancy complicated by gestational diabetes. Design, Setting, and Participants This retrospective cohort study used data from April 1, 2007, to October 12, 2023, from the Merative MarketScan commercial database. Participants were commercially insured females aged 12 to 55 years with a single delivery and no preexisting CKM disorders before delivery. Follow-up began after delivery and continued until incident diagnosis, disenrollment, or end of data availability. Data were analyzed from August 2025 to March 2026. Exposure Gestational diabetes, identified using diagnosis codes requiring 1 or more inpatient claims or 2 or more outpatient claims during pregnancy. Main Outcomes and Measures Incident postpartum diagnoses of obesity, hypertension, hyperlipidemia, prediabetes, type 2 diabetes, metabolic syndrome, chronic kidney disease, and cardiovascular disease. Cox proportional hazards regression models estimated adjusted hazard ratios (AHRs) and 95% CIs. Temporal patterns were assessed using postpartum interval-specific HRs and year-specific incidence rate ratios. Results Of 1 153 998 females (mean [SD] age, 28.0 [5.8] years), 95 103 (8.2%) had gestational diabetes; median follow-up was 2.4 years (IQR, 1.6-3.8 years). Compared with individuals without gestational diabetes, those with gestational diabetes had higher crude incidence rates per 1000 person-years of type 2 diabetes (9.9 vs 1.0), prediabetes (12.9 vs 2.5), hyperlipidemia (19.9 vs 10.1), hypertension (13.9 vs 8.1), and obesity (26.3 vs 15.2). In adjusted models, gestational diabetes was associated with dysglycemia, including type 2 diabetes (time-averaged AHR, 10.02; 95% CI, 9.53-10.52) and prediabetes (AHR, 5.32; 95% CI, 5.12-5.53), metabolic syndrome (AHR, 2.72, 95% CI, 2.49-2.98), hyperlipidemia (AHR, 2.00; 95% CI, 1.95-2.06), hypertension (AHR, 1.76; 95% CI, 1.70-1.82), and obesity (AHR, 1.75; 95% CI, 1.71-1.79). Composite cardiovascular disease risk was elevated (AHR, 1.28; 95% CI, 1.18-1.40), whereas chronic kidney disease was not (AHR, 0.96; 95% CI, 0.76-1.22). Conclusions and Relevance In this cohort study, gestational diabetes was associated with increased postpartum risk across multiple metabolic disorders. These findings suggest that postpartum care after gestational diabetes may need to extend beyond glucose monitoring to include broader cardiometabolic risk surveillance.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.